Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Immunogenicity of the quadrivalent human papillomavirus (type 6/11/16/18) vaccine in males 16 to 26 years old.

Hillman RJ, Giuliano AR, Palefsky JM, Goldstone S, Moreira ED Jr, Vardas E, Aranda C, Jessen H, Ferris DG, Coutlee F, Marshall JB, Vuocolo S, Haupt RM, Guris D, Garner EI.

Clin Vaccine Immunol. 2012 Feb;19(2):261-7. doi: 10.1128/CVI.05208-11. Epub 2011 Dec 7.

2.

Human papillomavirus quadrivalent (types 6, 11, 16, 18) recombinant vaccine (Gardasil).

Siddiqui MA, Perry CM.

Drugs. 2006;66(9):1263-71; discussion 1272-3. Review.

PMID:
16827602
4.

A review of clinical trials of human papillomavirus prophylactic vaccines.

Schiller JT, Castellsagué X, Garland SM.

Vaccine. 2012 Nov 20;30 Suppl 5:F123-38. doi: 10.1016/j.vaccine.2012.04.108. Review.

6.
7.

The prophylactic role for the human papillomavirus quadrivalent vaccine in males.

Yancey AM, Pitlick JM, Forinash AB.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1314-8. doi: 10.1345/aph.1P017. Epub 2010 May 25. Review.

PMID:
20501891
8.

[Diseases caused by human papilloma viruses].

Zollner U, Schwarz TF.

Dtsch Med Wochenschr. 2011 May;136(20):1067-72. doi: 10.1055/s-0031-1275845. Epub 2011 May 10. Review. German.

PMID:
21560109
9.

Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males.

Garnock-Jones KP, Giuliano AR.

Drugs. 2011 Mar 26;71(5):591-602. doi: 10.2165/11205980-000000000-00000. Review.

10.

Clinical Inquiry: Does qHPV vaccine prevent anal intraepithelial neoplasia and condylomata in men?

Shum J, Kelsberg G, Safranek S.

J Fam Pract. 2015 Sep;64(9):581-3. Review.

PMID:
26546954
11.

An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results.

Schiller JT, Castellsagué X, Villa LL, Hildesheim A.

Vaccine. 2008 Aug 19;26 Suppl 10:K53-61. doi: 10.1016/j.vaccine.2008.06.002. Review.

12.

Integrating clinical, community, and policy perspectives on human papillomavirus vaccination.

Fernández ME, Allen JD, Mistry R, Kahn JA.

Annu Rev Public Health. 2010;31:235-52. doi: 10.1146/annurev.publhealth.012809.103609. Review.

13.

Monitoring of human papillomavirus vaccination.

Dillner J, Arbyn M, Unger E, Dillner L.

Clin Exp Immunol. 2011 Jan;163(1):17-25. doi: 10.1111/j.1365-2249.2010.04268.x. Epub 2010 Nov 9. Review.

14.

The Human Papillomavirus Vaccine: Current Perspective and Future Role in Prevention and Treatment of Anal Intraepithelial Neoplasia and Anal Cancer.

Mensah FA, Mehta MR, Lewis JS Jr, Lockhart AC.

Oncologist. 2016 Apr;21(4):453-60. doi: 10.1634/theoncologist.2015-0075. Epub 2016 Mar 9. Review.

15.

[Human papillomavirus vaccine. Efficacy and safety].

Bruni L, Serrano B, Bosch X, Castellsagué X.

Enferm Infecc Microbiol Clin. 2015 May;33(5):342-54. doi: 10.1016/j.eimc.2015.03.018. Epub 2015 Apr 30. Review. Spanish.

PMID:
25937455
16.

Development of a human papillomavirus competitive luminex immunoassay for 9 HPV types.

Roberts C, Green T, Hess E, Matys K, Brown MJ, Haupt RM, Luxembourg A, Vuocolo S, Saah A, Antonello J.

Hum Vaccin Immunother. 2014;10(8):2168-74. doi: 10.4161/hv.29205. Review.

17.

Rome Consensus Conference - statement; human papilloma virus diseases in males.

Lenzi A, Mirone V, Gentile V, Bartoletti R, Ficarra V, Foresta C, Mariani L, Mazzoli S, Parisi SG, Perino A, Picardo M, Zotti CM.

BMC Public Health. 2013 Feb 7;13:117. doi: 10.1186/1471-2458-13-117.

18.

Epithelial cell responses to infection with human papillomavirus.

Stanley MA.

Clin Microbiol Rev. 2012 Apr;25(2):215-22. doi: 10.1128/CMR.05028-11. Review.

19.

Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy.

Nakalembe M, Mirembe FM, Banura C.

Infect Agent Cancer. 2015 Jun 12;10:17. doi: 10.1186/s13027-015-0012-2. eCollection 2015. Review.

20.

Spotlight on the 9-valent HPV vaccine.

Lopalco PL.

Drug Des Devel Ther. 2016 Dec 20;11:35-44. doi: 10.2147/DDDT.S91018. eCollection 2017. Review.

Supplemental Content

Support Center